menu
Health

Cost of HIV drugs including PrEP could reduce following court ruling

James Ledward July 25, 2018

Landmark court ruling could be game changer for costings of PrEP and other HIV drugs. A ruling today from the European Court of Justice (ECJ) suggests that Gilead’s patent for Truvada, the drug used to treat many people living with HIV, and the drug used for PrEP, may be under threat.

Read More
Health

HIV prevention drug PrEP available on the NHS from September

James Ledward August 3, 2017

Pre-exposure prophylaxis (PrEP) will be available through the NHS from September, as part of a three-year trial. The announcement comes a year and a day after an historic win for NAT (National AIDS Trust) at the High Court that confirmed the NHS’s legal ability to fund the drug, which stops people from getting HIV.

Read More
Community News

NHS Scotland makes history and approves anti-HIV drug on prescription for people at risk of catching HIV in Scotland

James Ledward April 10, 2017

Following a rigorous process, the Scottish Medicines Consortium (SMC) announce that PrEP, the HIV prevention drug, has been deemed a cost-effective treatment to prevent the transmission of HIV in Scotland.

Read More
Health

New PrEP trial will benefit 10,000 people

James Ledward December 4, 2016

News that NHS England is to fund a PrEP clinical trial for 10,000 people over next 3 years costing £10million receives cautious welcome. NHS England agrees to extend national HIV prevention programme with Public Health England.

Read More
X